MX9203777A - Inhibidores aromaticos de esteroide 5-&-reductasa. - Google Patents

Inhibidores aromaticos de esteroide 5-&-reductasa.

Info

Publication number
MX9203777A
MX9203777A MX9203777A MX9203777A MX9203777A MX 9203777 A MX9203777 A MX 9203777A MX 9203777 A MX9203777 A MX 9203777A MX 9203777 A MX9203777 A MX 9203777A MX 9203777 A MX9203777 A MX 9203777A
Authority
MX
Mexico
Prior art keywords
reductasa
steroid inhibitors
aromatic steroid
aromatic
inhibitors
Prior art date
Application number
MX9203777A
Other languages
English (en)
Inventor
Dennis A Holt
Mark A Levy
Brian W Metcalf
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX9203777A publication Critical patent/MX9203777A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0095Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 carbon in position 21 is part of carboxylic group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
MX9203777A 1988-05-25 1992-06-29 Inhibidores aromaticos de esteroide 5-&-reductasa. MX9203777A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19853488A 1988-05-25 1988-05-25
US07/380,226 US4954446A (en) 1988-05-25 1989-07-14 Aromatic steroid 5-α-reductase inhibitors

Publications (1)

Publication Number Publication Date
MX9203777A true MX9203777A (es) 1992-09-01

Family

ID=26893879

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203777A MX9203777A (es) 1988-05-25 1992-06-29 Inhibidores aromaticos de esteroide 5-&-reductasa.

Country Status (2)

Country Link
US (1) US4954446A (es)
MX (1) MX9203777A (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA938B (en) * 1992-01-06 1994-06-16 Smithkline Beecham Corp Preparation of benzo esters and benzo acids
WO1993022333A1 (en) * 1992-04-30 1993-11-11 Smithkline Beecham Corporation 17α AND 17β-SUBSTITUTED ESTRA-1,3,5(10)-TRIENE-3-CARBOXYLIC ACID
GB9213835D0 (en) * 1992-06-30 1992-08-12 Smithkline Beecham Corp Compounds
US5683995A (en) * 1992-11-18 1997-11-04 Smithkline Beecham Corporation 17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors
US5641765A (en) * 1992-11-18 1997-06-24 Smithkline Beecham Corporation 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
AP9300589A0 (en) * 1992-11-18 1994-01-31 Smithkline Beecham Corp Novel 17a and 17b substituted acyl-3-carboxy 3,5-diene steroidal compounds, pharmaceutical compositions containing these compounds, and methods for using these compounds to inhibit steroid 5-a-reductase.
US5604214A (en) * 1993-03-10 1997-02-18 Pfizer Inc. Reduction of boar odor in meat
GB9304909D0 (en) * 1993-03-10 1993-04-28 Smithkline Beecham Corp Methods
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
WO1995028413A1 (en) * 1994-04-15 1995-10-26 Smithkline Beecham Corporation 17β-SUBSTITUTED 3-CARBOXY STEROIDS THAT INHIBIT 5-α-REDUCTASE
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US6372712B1 (en) 1998-05-22 2002-04-16 The Board Of Trustees Of The Leland Stanford Jr. University Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
PT1889198E (pt) 2005-04-28 2015-03-06 Proteus Digital Health Inc Sistema fármaco-informático
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
NZ596876A (en) 2009-05-06 2014-01-31 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191759A (en) * 1978-04-13 1980-03-04 Merck & Co., Inc. N-substituted-17β-carbamoylandrost-4-en-3-one 5α reductase inhibitors
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4317817A (en) * 1979-08-27 1982-03-02 Richardson-Merrell Inc. Novel steroid 5α-reductase inhibitors
DK465481A (da) * 1980-11-21 1982-05-22 Hoffmann La Roche Fremgangsmaade til fremstilling af d-homostemoider

Also Published As

Publication number Publication date
US4954446A (en) 1990-09-04

Similar Documents

Publication Publication Date Title
FI896014A0 (fi) Heterocykliska derivat.
ATE74125T1 (de) Didehydro-vitamin d3-derivate.
FI904101A0 (fi) 17b-acyl-4-aza-5a-androst-1-en-3-on- som 5a-reduktasinhibitorer.
DE69017938T2 (de) Steroid-Derivate.
ATE129716T1 (de) Alpha-glukosidase-inhibitoren.
FI904729A0 (fi) Inhibitorer av retrovirala proteaser.
DE68904083T2 (de) Hmg-coa-reduktaseinhibitoren.
DE69008682D1 (de) Guanidinobenzolderivate.
MX9203777A (es) Inhibidores aromaticos de esteroide 5-&-reductasa.
FI894685A0 (fi) Dispenser foer utdosering av pastaprodukter.
DE68911726T2 (de) Luciferase.
DE68901091D1 (de) Hmg-coa-reduktaseinhibitoren.
ATE119146T1 (de) Substituierte bicycloheptadionderivate.
DE68911192T2 (de) Phosphonoalkylpurin-Derivate.
DE69017657D1 (de) Pyridinderivate.
DE3872213T2 (de) 5-substituierte ornithin-derivate.
DE59000510D1 (de) N-phenyltetrahydroindazolderivate.
FI910470A0 (fi) Regel.
DE68913856D1 (de) Cycloalkylthiazol-Derivate.
DE59003499D1 (de) 3-Cyano-4-phenyl-pyrrol-Derivate.
DE58903771D1 (de) Schranke.
DE68906427D1 (de) Propan-derivate.
DE58900371D1 (de) 3-cyano-4-phenyl-pyrrol-derivate.
DE69001450D1 (de) Dihydroxynaphthalin-derivate.
DE69023929T2 (de) Naphtalenderivate.